probenecid has been researched along with Groenblad-Strandberg Syndrome in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iliás, A | 1 |
| Urbán, Z | 1 |
| Seidl, TL | 1 |
| Le Saux, O | 1 |
| Sinkó, E | 1 |
| Boyd, CD | 1 |
| Sarkadi, B | 1 |
| Váradi, A | 1 |
| Osti, MH | 1 |
| Scardamaglia, L | 1 |
2 other studies available for probenecid and Groenblad-Strandberg Syndrome
| Article | Year |
|---|---|
Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6).
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Biological Transport; Blotting, Western; | 2002 |
Treatment of pseudoxanthoma elasticum with probenecid.
Topics: Adult; Female; Humans; Probenecid; Pseudoxanthoma Elasticum; Treatment Outcome; Uricosuric Agents | 2021 |